Scholars Central

Review articlePublished 2020

Financial Performance Evaluation : Empirical Evidence of Pharmaceutical Companies in Indonesia

Authors: Endri Endri, Desi Susanti, Lamminar Hutabarat, Torang P. Simanjuntak, Susi Handayani

Systematic Reviews in Pharmacy

Volume 11 · Issue 6 · Pages 803–816

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

This study aims to evaluate the financial performance of a pharmaceutical company that has been listed on the Indonesia Stock Exchange (IDX). The sample objects that the authors use in this study are nine pharmaceutical companies listed on the Indonesia Stock Exchange during the 2014-2018 period. The method of evaluating financial performance that I use is to use financial ratio analysis consisting of; liquidity ratios, activity ratios, solvency ratios, and profitability ratios and have been supplemented by DuPont analysis. The results that the authors get in this study prove that all financial ratios during the observation period experienced quite fluctuating changes. The liquidity ratio shows a high enough number which means that under the company's ability to pay off short-term liabilities, it is quite strong. The results of the calculation of the activity ratio obtained by the author also gives results that show that some pharmaceutical companies are quite efficient in the use of their assets in a company. The solvency ratio obtained by the authors from observations in the study period shows that pharmaceutical companies also have a debt large enough to be risky because of high interest and principal costs in payments. Earnings obtained by shareholders are quite large as indicated by profitability ratios through the analysis of three analyzes namely the analysis of ROI, ROE and DuPont which have positive values. How to Cite this Article Pubmed Style Endri Endri, Desi Susanti, Lamminar Hutabarat, Torang P. Simanjuntak, Susi Handayani. Financial Performance Evaluation : Empirical Evidence of Pharmaceutical Companies in Indonesia. SRP. 2020; 11(6): 803-816. doi:10.31838/srp.2020.6.117 Web Style Endri Endri, Desi Susanti, Lamminar Hutabarat, Torang P. Simanjuntak, Susi Handayani. Financial Performance Evaluation : Empirical Evidence of Pharmaceutical Companies in Indonesia. http://www.sysrevpharm.org/?mno=119068 [Access: March 29, 2021]. doi:10.31838/srp.2020.6.117 AMA (American Medical Association) Style Endri Endri, Desi Susanti, Lamminar Hutabarat, Torang P. Simanjuntak, Susi Handayani. Financial Performance Evaluation : Empirical Evidence of Pharmaceutical Companies in Indonesia. SRP. 2020; 11(6): 803-816. doi:10.31838/srp.2020.6.117 Vancouver/ICMJE Style Endri Endri, Desi Susanti, Lamminar Hutabarat, Torang P. Simanjuntak, Susi Handayani. Financial Performance Evaluation : Empirical Evidence of Pharmaceutical Companies in Indonesia. SRP. (2020), [cited March 29, 2021]; 11(6): 803-816. doi:10.31838/srp.2020.6.117 Harvard Style Endri Endri, Desi Susanti, Lamminar Hutabarat, Torang P. Simanjuntak, Susi Handayani (2020) Financial Performance Evaluation : Empirical Evidence of Pharmaceutical Companies in Indonesia. SRP, 11 (6), 803-816. doi:10.31838/srp.2020.6.117 Turabian Style Endri Endri, Desi Susanti, Lamminar Hutabarat, Torang P. Simanjuntak, Susi Handayani. 2020. Financial Performance Evaluation : Empirical Evidence of Pharmaceutical Companies in Indonesia. Systematic Reviews in Pharmacy, 11 (6), 803-816. doi:10.31838/srp.2020.6.117 Chicago Style Endri Endri, Desi Susanti, Lamminar Hutabarat, Torang P. Simanjuntak, Susi Handayani. "Financial Performance Evaluation : Empirical Evidence of Pharmaceutical Companies in Indonesia." Systematic Reviews in Pharmacy 11 (2020), 803-816. doi:10.31838/srp.2020.6.117 MLA (The Modern Language Association) Style Endri Endri, Desi Susanti, Lamminar Hutabarat, Torang P. Simanjuntak, Susi Handayani. "Financial Performance Evaluation : Empirical Evidence of Pharmaceutical Companies in Indonesia." Systematic Reviews in Pharmacy 11.6 (2020), 803-816. Print. doi:10.31838/srp.2020.6.117 APA (American Psychological Association) Style Endri Endri, Desi Susanti, Lamminar Hutabarat, Torang P. Simanjuntak, Susi Handayani (2020) Financial Performance Evaluation : Empirical Evidence of Pharmaceutical Companies in Indonesia. Systematic Reviews in Pharmacy, 11 (6), 803-816. doi:10.31838/srp.2020.6.117

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Systematic Reviews in Pharmacy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalSystematic Reviews in Pharmacy
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Endri Endri”
  • BylineArticles whose byline prints “Desi Susanti”
  • BylineArticles whose byline prints “Lamminar Hutabarat”
  • BylineArticles whose byline prints “Torang P. Simanjuntak”
  • BylineArticles whose byline prints “Susi Handayani”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels